Fig. 8From: Safety, pharmacokinetics and exploratory pro-cognitive effects of HTL0018318, a selective M1 receptor agonist, in healthy younger adult and elderly subjects: a multiple ascending dose studyEffects on the MMT reversed condition performance in younger adults (a) and elderly subjects (b)Back to article page